Nissui Pharmaceutical Co., Ltd.

TSE:4550 Stock Report

Market Cap: JP¥16.9b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Nissui Pharmaceutical Past Earnings Performance

Past criteria checks 1/6

Key information

-11.2%

Earnings growth rate

-11.2%

EPS growth rate

Medical Equipment Industry Growth7.8%
Revenue growth rate6.3%
Return on equity8.5%
Net Margin5.9%
Last Earnings Update30 Sep 2022

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Nissui Pharmaceutical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSE:4550 Revenue, expenses and earnings (JPY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2217,1811,0113,283691
30 Jun 2216,4149493,215691
31 Mar 2216,6571,1463,003691
31 Dec 2115,3911,0792,912643
30 Sep 2115,6111,0432,913643
30 Jun 2114,4389982,762643
31 Mar 2112,3846482,761643
31 Dec 2012,0573623,003695
30 Sep 2011,6523483,285695
30 Jun 2012,0674413,612695
31 Mar 2012,7734013,885695
31 Dec 1912,6338143,854640
30 Sep 1912,6358683,846640
30 Jun 1912,5205843,793640
31 Mar 1912,5497843,795640
31 Dec 1812,4207663,606772
30 Sep 1812,3517323,624772
30 Jun 1812,1591,1463,589772
31 Mar 1812,3291,1753,651772
31 Dec 1712,4551,7653,652866
30 Sep 1712,7382,2223,661866
31 Mar 1712,8251,9023,815866

Quality Earnings: 4550 has high quality earnings.

Growing Profit Margin: 4550's current net profit margins (5.9%) are lower than last year (6.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4550's earnings have declined by 11.2% per year over the past 5 years.

Accelerating Growth: 4550's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4550 had negative earnings growth (-3.1%) over the past year, making it difficult to compare to the Medical Equipment industry average (-0.5%).


Return on Equity

High ROE: 4550's Return on Equity (8.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies